Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).

Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 02; 39(1):182-192.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Pancreatic Ductal
Dose-Response Relationship, Drug
Fluorouracil
Humans
Interleukin-10
Kaplan-Meier Estimate
Leucovorin
Middle Aged
Neoplasm Staging
Organoplatinum Compounds
Pancreatic Neoplasms
Polyethylene Glycols
Response Evaluation Criteria in Solid Tumors

authors with profiles

Raid Aljumaily